NASDAQ · RARE
Ultragenyx Pharmaceutical Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
Price chart by TradingView
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for RARE: Nov 03, 2026
Ultragenyx Pharmaceutical Inc. Common Stock is expected to report earnings on 11/03/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 6 analysts' forecasts, the consensus EPS forecast for the quarter is $-1.15. The reported EPS for the same quarter last year was $-1.81.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-1.15 | $-1.06 | $-1.29 | 6 |
| Dec 2026 | $-0.23 | $2.32 | $-1.20 | 5 |
| Mar 2027 | $-0.54 | $0.06 | $-1.02 | 5 |
| Jun 2027 | $-0.05 | $0.91 | $-0.54 | 5 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Barchart · RTTNews- Zacks · Oct 28, 9:00 AM EDTAnalysts Estimate Cytek Biosciences, Inc. (CTKB) to Report a Decline in Earnings: What to Look Out forCytek Biosciences (CTKB) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Zacks · Oct 28, 6:10 AM EDTGSK (GSK) Q3 Earnings and Revenues Beat EstimatesGlaxo (GSK) delivered earnings and revenue surprises of +5.00% and +1.24%, respectively, for the quarter ended September 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Oct 27, 9:00 AM EDTUltragenyx (RARE) May Report Negative Earnings: Know the Trend Ahead of Q3 ReleaseUltragenyx (RARE) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
- Barchart · Oct 21, 2:24 PM EDTStocks Finish Mostly Higher on Earnings OptimismThe S&P 500 Index ($SPX ) (SPY ) closed up by +0.38% on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed up by +1.02%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.13%. December E-mini S&P futures (ESZ26 ) rose +0.33%, and December E-mini…
- Barchart · Oct 20, 6:45 PM EDTStocks Pressured by Tech Stock Weakness and Higher Crude Oil PricesThe S&P 500 Index ($SPX ) (SPY ) is down by -0.15% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.57%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is down -0.82%. December E-mini S&P futures (ESZ26 ) are down -0.10%, and December E-mini…
- Barchart · Oct 20, 6:14 PM EDTStocks Rebound on Strong Earnings and Lower Bond YieldsThe S&P 500 Index ($SPX ) (SPY ) is up by +0.60% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +1.23%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.12%. December E-mini S&P futures (ESZ26 ) are up +0.60%, and December E-mini…
- RTTNews · Oct 16, 3:02 PM EDTFDA Drug Approvals In September 2026(RTTNews) – The U.S. Food and Drug Administration (FDA) approved 13 drugs in September 2026, spanning first-in-class therapies, treatments for rare diseases, and new options for patients with serious conditions.With the month yielding a mix of new therapies and expanded treatment
- Zacks · Oct 15, 9:33 AM EDTRARE's Fayuvi Approval Spurs Second PRV Sale Worth $203M in a WeekUltragenyx agrees to sell its Fayuvi-linked PRV for $203 million, marking its second voucher sale in one week and adding non-dilutive funding for rare-disease programs.
- Barchart · Oct 14, 1:48 PM EDTStocks Finish Lower Ahead of Wednesday’s CPI ReportThe S&P 500 Index ($SPX ) (SPY ) closed down by -0.02% on Tuesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.35%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.31%. December E-mini S&P futures (ESZ26 ) fell -0.02%, and December E-mini…
- RTTNews · Oct 14, 9:45 AM EDTUltragenyx To Sell Rare Pediatric Disease Priority Review Voucher For $203 Mln(RTTNews) – Ultragenyx Pharmaceutical Inc. (RARE) announced on Wednesday that it has agreed to sell a Rare Pediatric Disease Priority Review Voucher for $203 million.
- Zacks · Oct 14, 9:30 AM EDTCan RARE's Approved Product Portfolio Drive Its Next Growth Phase?Ultragenyx's established rare-disease treatments continue to support revenue growth, while two newly approved gene therapies offer additional commercial opportunities.
- Barchart · Oct 8, 2:06 PM EDTStocks Settle Lower on Higher Bond YieldsThe S&P 500 Index ($SPX ) (SPY ) closed down by -0.22% on Wednesday, the Dow Jones Industrial Average ($DOWI ) (DIA ) closed down by -0.66%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) closed down -0.21%. December E-mini S&P futures (ESZ26 ) fell -0.27%, and December E-mini…
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Company profile by TradingView
Financials
Loading fundamental data…
Fundamental data by TradingView
More headlines
More stories for Ultragenyx Pharmaceutical Inc. from TradingView. Coverage varies.
Loading related news…
Related news by TradingView
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.